Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP was delisted on the 5th of October, 2023.
118 hedge funds and large institutions have $869M invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 21 closing their positions.
499% more call options, than puts
Call options by funds: $40.1M | Put options by funds: $6.7M
150% more capital invested
Capital invested by funds: $348M → $869M (+$522M)
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
110% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 21
87% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 23
24% more funds holding
Funds holding: 95 → 118 (+23)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$25.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.3M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$17.9M |
| 4 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$12.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRM
Michael R. Murphy
|
-$42.1M |
| 2 |
DM
Deerfield Management
New York
|
-$37.6M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$6.32M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$5.09M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.01M |
HZNP Hedge Fund Activity: Q1 2014 in Review
118 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q1 2014, worth a combined $869M — up 150% from $348M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new HZNP positions and 21 closed out — a net gain of 23 holders — while 43 added to existing stakes and 23 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $25.3M. The largest seller was Michael R. Murphy, cutting an estimated $42.1M.
- 118 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q1 2014, up from 95 in Q4 2013.
- Funds reported $869M of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q1 2014, up 150% quarter-over-quarter.
- 44 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q1 2014 and 21 closed out, a net change of +23 holders.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q1 2014 was Visium Asset Management, an estimated $25.3M added.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q1 2014 was Michael R. Murphy, an estimated $42.1M sold.
Based on aggregated 13F filings for Q1 2014.